Abstract
Diabetes is the result of the insufficiency or dysfunction of pancreatic beta cells alone or in combination with insulin resistance. The replacement or regeneration of beta cells can effectively reverse diabetes in humans and rodents. Therefore, the identification of novel small molecules that promote pancreatic beta-cell proliferation is an attractive approach for diabetic therapy. While numerous hormones, small molecules, and growth factors are able to drive rodent beta cells to replicate, only a few small molecules have demonstrated the ability to stimulate human beta-cell proliferation. Hence, there is an urgent need for therapeutic agents that induce regeneration and expansion of adult human beta cells. Here, we describe a detailed protocol for coating chamber slides, culturing primary islets, performing islet cell disassociation, seeding cells on chamber slides, treating islet cells with compounds or infecting them with adenovirus, immunostaining of proliferation markers and imaging, and data analysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Buter PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110
Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314:1360–1368
Gregg BE, Moore PC, Demozay D, Hall BA, Li M, Husain A et al (2012) Formation of a human beta-cell population within pancreatic islets is set early in life. J Clin Endocrinol Metab 97:3197–3206
Matveyenko AV, Butler PC (2008) Relationship between beta-cell mass and diabetes onset. Diab. Obes Metab 10:23–31
Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221–2228
Bleich D, Jackson RA, Soeldner JS, Eisenbarth GS (1990) Analysis of metabolic progression to type I diabetes in ICA+ relatives of patients with type I diabetes. Diabetes Care 13:111–118
Lindgren CM, McCarthy MI (2008) Mechanisms of disease: genetic insights into the etiology of type 2 diabetes and obesity. Nat Clin Pract Endocrinol Metab 4:156–163
Pepper AR, Gala-Lopez B, Ziff O, Shapiro AJ (2013) Current status of clinical islet transplantation. World J Transplant 3:48–53
Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL et al (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230–238
Fiaschi-Taesch NM, Kleinberger JW, Salim FG, Troxell R, Wills R, Tanwir M et al (2013) Human pancreatic beta-cell G1/S molecule cell cycle atlas. Diabetes 62:2450–2459
Heit JJ, Karnik SK, Kim SK (2006) Intrinsic regulators of pancreatic beta-cell proliferation. Annu Rev Cell Dev Biol 22:311–338
Takane KK, Kleinberger JW, Salim FG, Fiaschi-Taesch NM, Stewart AF (2012) Regulated and reversible induction of adult human beta-cell replication. Diabetes 61:418–424
Salic A, Mitchison TJ (2008) A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc Natl Acad Sci U S A 105:2415–2420
Preusser M, Heinzl H, Gelpi E, Höftberger R, Fischer I, Pipp I et al (2008) Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker. Histopathology 53:39–47
Endl E, Steinbach P, Knüchel R, Hofstädter F (1997) Analysis of cell cycle-related Ki-67 and p120 expression by flow cytometric BrdUrd-Hoechst/7AAD and immunolabeling technique. Cytometry 29:233–241
Healy S, Khan P, He S, Davie JR (2012) Histone H3 phosphorylation, immediate-early gene expression, and the nucleosomal response: a historical perspective. Biochem Cell Biol 90:39–54
Aamodt KI, Aramandla R, Brown JJ, Fiaschi-Taesch NM, Wang P, Stewart AF et al (2016) Development of a reliable automated screening system to identify small molecules and biologics that promote human β-cell regeneration. Am J Phys Endocrinol Metab 311:E859–E868
Dirice E, Walpita D, Vetere A, Meier BC, Kahraman S, Hu J et al (2016) Inhibition of DYRK1A stimulates human beta-cell proliferation. Diabetes 65:1660–1671
Shen W, Taylor B, Jin Q, Nguyen-Tran V, Meeusen S, Zhang YQ et al (2015) Inhibition of DYRK1A and GSK3B induces human β-cell proliferation. Nat Commun 6:8372
Wang P, Alvarez-Perez J-C, Felsenfeld DP, Liu H, Sivendran S, Bender A et al (2015) A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat Med 21:383–388
Ricordi C, Rastellini C (2000) Methods in pancreatic islet separation. In: Methods in cell transplantation. RG Landes, Austin, pp 433–438
Walpita D, Wagner BK (2014) Evaluation of compounds in primary human islet cell culture. Curr Prot. Chem Biol 6:157–168
Acknowledgements
The authors thank Dr. Andrew Stewart and the members of the Stewart lab, Dr. Adolfo Garcia-Ocaña (all at Icahn School of Medicine at Mount Sinai, New York, NY), for invaluable and continuous insight. The authors thank the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Integrated Islet Distribution Program and Dr. Tatsuya Kin (Alberta Diabetes Institute, Edmonton, Alberta, Canada) for providing human islets . This work was supported by JDRF grant 2-SRA-2015-62-Q-R; National Institutes of Health grants R-01 DK105015 and T32 GM 062754; and the Human Islet and Adenovirus Core of the Einstein-Mount Sinai Diabetes Research Center P30 DK020541-38.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Ackeifi, C.A., Swartz, E.A., Wang, P. (2018). Cell-Based Methods to Identify Inducers of Human Pancreatic Beta-Cell Proliferation. In: Wagner, B. (eds) Phenotypic Screening. Methods in Molecular Biology, vol 1787. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7847-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7847-2_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7846-5
Online ISBN: 978-1-4939-7847-2
eBook Packages: Springer Protocols